← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Nanovir, Llc.
Kalamazoo, MI
$7,692,828
Total funding
4
Grants
Funding over time
peak $2M · FY2005–12$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
Funding mix
By agency
NIH$7,692,828 · 4
By mechanism
R42$5,942,780 · 2
R41$1,750,048 · 2
Investigators at Nanovir, Llc.
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
Not enough data
All-Time
Most funded here, all years
Largest grants
Pre-clinical Development of a Broad Spectrum Antiviral Compound to Treat Human Pa$1,000,000
R42 · FY2011 · AI
Pre-Clinical HPV16 Antiviral Compound Development$1,000,000
R42 · FY2008 · AI
Pre-clinical Development of a Broad Spectrum Antiviral Compound to Treat Human Pa$1,000,000
R42 · FY2010 · AI
Pre-clinical Development of a Broad Spectrum Antiviral Compound to Treat Human Pa$1,000,000
R42 · FY2012 · AI
Pre-Clinical HPV16 Antiviral Compound Development$977,163
R42 · FY2009 · AI
Pre-Clinical HPV16 Antiviral Compound Development$965,617
R42 · FY2010 · AI
Antiviral Compounds that Target HPV18 DNA$498,425
R41 · FY2008 · AI
Antiviral Compounds that Target HPV18 DNA$480,768
R41 · FY2007 · AI
Antiviral Compounds for Human Papillomavirus 16$388,487
R41 · FY2005 · AI
Antiviral Compounds for Human Papillomavirus 16$382,368
R41 · FY2004 · AI